Stock Snapshot

Market Snapshot

BSE Sensex: 59870.96 0.54%
BSE 500: 23726.21 -0.22%
BSE 200: 7558.29 -0.22%
BSE 100: 17937.14 0.01%
BSE Mid-Cap: 24498.72 -0.58%
BSE Small-Cap: 28127.67 -0.28%
BANKEX: 46444.06 0.79%
BSE IT Sector: 29780.69 0.42%
Nifty 50: 17688.4 0.15%
Nifty 500: 14907.55 -0.19%
Nifty 200: 9205.95 -0.17%
Nifty 100: 17576.25 -0.14%
Nifty Midcap 100: 30552.35 -0.40%
Nifty Small 100: 9466.8 -0.37%
Nifty IT: 29896.6 0.53%
Nifty PSU Bank: 3880 -3.16%

News:

Tata Motors total sales rises ...
Hotel shares rally after Union...
Maruti Suzuki total sales rise...
Cigarette makers in focus afte...
Navneet Education Ltd spurts 2...

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

01 Feb 2023 | 02:17 PM

1,258.75

12.05 (0.97%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-18.44%

Return (1Y)

Underperformed S&P BSE Healthcare by 11.75%
More Volatile

1.21%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 0.25%
Not so consistent

6/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,735

1,245

News & Announcements

GlaxoSmithKline Pharmaceuticals to conduct board meeting
20 days ago

GlaxoSmithKline Pharmaceuticals to conduct board meeting

12 - Jan - 2023 12:00 AM | 20 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 February 2023.
Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals consolidated net profit declines 5.30% in the September 2022 quarter
81 days ago

Glaxosmithkline Pharmaceuticals consolidated net profit declines 5.30% in the September 2022 quarter

11 - Nov - 2022 12:00 AM | 81 days ago

Net profit of Glaxosmithkline Pharmaceuticals declined 5.30% to Rs 193.42 crore in the quarter ended September 2022 as against Rs 204.24 crore during the previous quarter ended September 2021. Sales declined 1.85% to Rs 916.87 crore in the quarter ended September 2022 as against Rs 934.11 crore during the previous quarter ended September 2021.
Particulars Quarter Ended
Sep. 2022 Sep. 2021 % Var.
Sales 916.87 934.11 -2
OPM % 28.02 27.42 -
PBDT 278.51 270.75 3
PBT 262.15 253.32 3
NP 193.42 204.24 -5
Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals to discuss results
92 days ago

GlaxoSmithKline Pharmaceuticals to discuss results

01 - Nov - 2022 12:00 AM | 92 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2022.
Powered by Capital Market - Live News
Board of Glaxosmithkline Pharmaceuticals approves change in MD
106 days ago

Board of Glaxosmithkline Pharmaceuticals approves change in MD

17 - Oct - 2022 12:00 AM | 106 days ago

The Board of Glaxosmithkline Pharmaceuticals at its meeting held on 17 October 2022 has approved the appointment of Bhushan Akshikar (DIN: 09112346) as a Managing Director. He succeeds Sridhar Venkatesh who is moving to a new senior role within GSK Group effective 1 December 2022.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Glaxosmithkline Pharma Ltd is trading very close to its 52 Week Low
FII shareholding in Glaxosmithkline Pharma Ltd has increased by 5.3% since past 3 Months
MF shareholding in Glaxosmithkline Pharma Ltd has increased by 7.69% since past 3 Months
FII shareholding in Glaxosmithkline Pharma Ltd has increased by 12.01% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2022	Sep. 2021	% Var.
Sales	916.87	934.11	-2
OPM %	28.02	27.42	-
PBDT	278.51	270.75	3
PBT	262.15	253.32	3
NP	193.42	204.24	-5

General Notifications

My Notifications

Research Notifications

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE Pharmaceuticals, Mid Cap

1,258.75 12.05 (0.97%)

News & Announcements

Price vs Volume

Stock Trivia

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Mid Cap

1,258.75

12.05 (0.97%)